US2014178971A1PendingUtilityA1
Toxin-Eating Bacteria and Bioremediation
Est. expiryOct 15, 2028(~2.2 yrs left)· nominal 20-yr term from priority
B08B 7/00C12R 2001/01C12N 1/205C12R 1/01
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Bacteria that can use antibiotics as a carbon source are provided. Methods and bacteria useful for bioremediation are also provided.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A clonal isolate of a bacterium that can use one or more antibiotics as a carbon source, wherein the bacterium has a 16S nucleic acid sequence comprising a GenBank Accession Number selected from the group consisting of EU515334, EU515335, EU515336, EU515337, EU515338, EU515339, EU515400, EU515401, EU515402, EU515403, EU515404, EU515405, EU515406, EU515407, EU515408, EU515409, EU515410, EU515411, EU515412, EU515413, EU515414, EU515415, EU515416, EU515417, EU515418, EU515419, EU515420, EU515421, EU515422, EU515423, EU515424, EU515425, EU515426, EU515427, EU515428, EU515429, EU515430, EU515431, EU515432, EU515433, EU515434, EU515435, EU515436, EU515437, EU515438, EU515439, EU515440, EU515441, EU515442, EU515443, EU515444, EU515445, EU515446, EU515447, EU515448, EU515449, EU515450, EU515451, EU515452, EU515453, EU515454, EU515455, EU515456, EU515457, EU515458, EU515459, EU515460, EU515461, EU515462, EU515463, EU515464, EU515465, EU515466, EU515467, EU515468, EU515469 EU515470, EU515471, EU515472, EU515473, EU515474, EU515475, EU515476, EU515477, EU515478, EU515479, EU515480, EU515481, EU515482, EU515483, EU515484, EU515485, EU515486, EU515487, EU515488, EU515489, EU515490, EU515491, EU515492, EU515493, EU515494, EU515495, EU515496, EU515497, EU515498, EU515499, EU515500, EU515501, EU515502, EU515503, EU515504, EU515505, EU515506, EU515507, EU515508, EU515509, EU515510, EU515511, EU515512, EU515513, EU515514, EU515515, EU515516, EU515517, EU515518, EU515519, EU515520, EU515521, EU515522, EU515523, EU515524, EU515525, EU515526, EU515527, EU515528, EU515529, EU515530, EU515531, EU515532, EU515533, EU515534, EU515535, EU515536, EU515537, EU515538, EU515539, EU515540, EU515541, EU515542, EU515543, EU515544, EU515545, EU515546, EU515547, EU515548, EU515549, EU515550, EU515551, EU515552, EU515553, EU515554, EU515555, EU515556, EU515557, EU515558, EU515559, EU515560, EU515561, EU515562, EU515563, EU515564, EU515565, EU515566, EU515567, EU515568, EU515569, EU515570, EU515571, EU515572, EU515573, EU515574, EU515575, EU515576, EU515577, EU515578, EU515579, EU515580, EU515581, EU515582, EU515583, EU515584, EU515585, EU515586, EU515587, EU515588, EU515589, EU515590, EU515591, EU515592, EU515593, EU515594, EU515595, EU515596, EU515597, EU515598, EU515599, EU515600, EU515601, EU515602, EU515603, EU515604, EU515605, EU515606, EU515607, EU515608, EU515609, EU515610, EU515611, EU515612, EU515613, EU515614, EU515615, EU515616, EU515617, EU515618, EU515619, EU515620, EU515621, EU515622 and EU515623.
2 . The bacterium of claim 1 , wherein one or more antibiotics are from the antibiotic class selected from the group consisting of pyrimidine derivative, sulfonamide, quinolone, glycopeptides, beta-lactam, amphenicols, aminoglycoside and amino acid derivative.
3 . The bacterium of claim 1 , wherein one or more antibiotics are selected from the group consisting of chloramphenicol, penicillin G, vancomycin, carbenicillin, ciprofloxacin, mafenide, kanamycin, sisomicin, amikacin, trimethropin, D-cycloserine, gentamicin, dicloxacillin, nalidixic acid, thiamphenicol, levofloxacin, sulfamethizole and sulfisoxazole.
4 . The bacterium of claim 1 , wherein the bacterium uses the one or more antibiotics as a sole carbon source.Join the waitlist — get patent alerts
Track US2014178971A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.